Dramamine
NDC Package 52904-962-04
Package Information
Dramamine is to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activityto prevent or treat motion sickness, see below:adults and children 12 years and overtake 1 to 2 chewable tablets every 4-6 hoursdo not take more than 8 chewable tablets in 24 hours, or as directed by a doctorchildren 6 to under 12 yearsgive 1/2 to 1 chewable tablet every 6-8 hoursdo not give more than 3 chewable tablets in 24 hours, or as directed by a doctorchildren 2 to under 6 yearsgive 1/2 chewable tablet every 6-8 hoursdo not give more than 1½ chewable tablets in 24 hours, or as directed by a doctor. Marketed by Select Corporation, this product is identified by NDC 52904-962 and is authorized under FDA application part336.
Identification & Billing
- RxCUI: 198603 - dimenhyDRINATE 50 MG Oral Tablet
- RxCUI: 198603 - dimenhydrinate 50 MG Oral Tablet
- RxCUI: 201716 - Dramamine 50 MG Oral Tablet
- RxCUI: 201716 - dimenhydrinate 50 MG Oral Tablet [Dramamine]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 52904 - Select Corporation
- 52904-962 - Dramamine
- 52904-962-04 - 1 POUCH in 1 BLISTER PACK / 2 TABLET in 1 POUCH
- 52904-962 - Dramamine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (52904-962). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 52904-962-04 identifies a specific commercial package of 1 pouch in 1 blister pack / 2 tablet in 1 pouch of Dramamine, labeled by Select Corporation. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Select Corporation on January 15, 2012. The current certification is valid through December 31, 2023.
How is this Select Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 52904096204. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.